Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Rhode Island Hospital
- Study ID
- NCT05990881
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Carpometacarpal Sprain
- Clostridium; Botulinum
- Thumb Sprain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Botulinum toxin — DRUGPatients in this group will receive an injection of Botulinum toxin.
- Standard-of-care corticosteroid injections — DRUGPatients in this group will receive an injection of corticosteroid injections, which are considered standard of care.
Study Details
The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no alternative to this injection medicine. This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid injection. The difference between Botox and steroid injections is that they are different medicines and work in different ways. Botox, as it is being used in this study, is not FDA-approved. It is therefore considered an investigational medicine.
Key Dates
- Start date
- Aug 27, 2023
- Status verified
- Nov 2024
- Primary completion
- Dec 31, 2025
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: ControlPatients in this group will receive standard-of-care corticosteroid injections.
- Experimental: Botulinum ToxinPatients in this group will receive a Botulinum Toxin injection.
Primary Outcome Measure
Thumb Pain [ Time Frame: Post-injection VAS scores will then be taken at each subsequent follow-up visit: 2-weeks, 1-month, 6-months, and 1-year (primary study endpoint). ]
Central Contacts
- Reena A Bhatt, MD(401) 444-2701
- Vinay Rao, MD8133856534
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| 235 Plain Street | Providence | Rhode Island | 02905 |